Back to Search
Start Over
Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
- Source :
-
British journal of haematology [Br J Haematol] 2021 Dec; Vol. 195 (5), pp. 703-705. Date of Electronic Publication: 2021 Aug 31. - Publication Year :
- 2021
- Subjects :
- 2019-nCoV Vaccine mRNA-1273 administration & dosage
2019-nCoV Vaccine mRNA-1273 adverse effects
Adult
Aged
Aged, 80 and over
BNT162 Vaccine administration & dosage
COVID-19 diagnosis
COVID-19 immunology
ChAdOx1 nCoV-19 administration & dosage
ChAdOx1 nCoV-19 adverse effects
Female
Follow-Up Studies
Hemorrhage chemically induced
Hemorrhage epidemiology
Humans
Male
Middle Aged
Platelet Count standards
Prospective Studies
Purpura, Thrombocytopenic, Idiopathic diagnosis
Purpura, Thrombocytopenic, Idiopathic epidemiology
SARS-CoV-2 genetics
SARS-CoV-2 immunology
Safety
BNT162 Vaccine adverse effects
COVID-19 complications
COVID-19 prevention & control
Purpura, Thrombocytopenic, Idiopathic etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2141
- Volume :
- 195
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- British journal of haematology
- Publication Type :
- Report
- Accession number :
- 34467525
- Full Text :
- https://doi.org/10.1111/bjh.17813